| Name | Title | Contact Details |
|---|
T3D Therapeutics` mission is to develop its lead drug product candidate, T3D-959, as a potential `First-in-Class`and `Best-in-Class` disease-modifying, breakthrough medicine for the treatment of Alzheimer`s disease with the potential to slow, stop or reverse the course of the disease. The Company is also seeking to maximize the therapeutic utility of T3D=959 and has initiated pre-clinical studies in Huntington’s Disease models.
IC Sciences Corporation is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
New Mexico Cancer Care is a Santa Fe, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CSL Behring is a biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products and providing them to people in more than 100 countries.
NanoGuardian is a Skokie, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.